Found 161 matching trials
Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma PHASE2 This is a prospective, monocenter, single arm, phase II trial in 33 patient...
Show More Location
Netherlands Cancer Institute-Antoni van Leeuwenhoek Ziekenhuis
Learn More & Join Trial
Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260) PHASE2 The purpose of this study is to investigate the characteristics of tumors i...
Show More Location
University of Connecticut Health Center
Learn More & Join Trial
Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis PHASE1 Melanoma is the deadliest form of skin cancer and its incidence has doubled...
Show More Location
Clinique Dermatologique/Radiologie Interventionnelle/Urologie/Gynécologie-CHU de Strasbourg/ICANS
Learn More & Join Trial
Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery PHASE2 Patients with malignant pleural mesothelioma stage I-III who have undergone...
Show More Location
Vivantes Klinikum Neukölln, Klinik für Hämatologie, Onkologie und Palliativmedizin
Learn More & Join Trial
NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma PHASE1 This research study is studying the drugs called NeoVax (a new type of pers...
Show More Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors PHASE2 This is a multi-site, three-cohort phase II trial of cabozantinib for IMDC ...
Show More Location
Fox Chase Cancer Center
Learn More & Join Trial
A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) PHASE1 The purpose of this study is to determine whether the combination of a neoa...
Show More Location
Johns Hopkins SKCCC
Learn More & Join Trial
F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer PHASE1 Prospective, open label, non-randomized, phase I/IIb study of F16IL2 in com...
Show More Location
Basel University Hospital
Learn More & Join Trial
A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma PHASE1 This clinical trial was designed to evaluate the safety and efficacy of Y90...
Show More Location
Study Chair Liu Chang , West China Hospital
Learn More & Join Trial
Neoadjuvant Nivolumab for Operable Esophageal Carcinoma PHASE2 This is a single arm phase II study, in which maximum 3 cycles of nivolumab...
Show More Learn More & Join Trial